Maggie Lu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Ultrasound and Hyperthermia Applications
- Nanoplatforms for cancer theranostics
- Photoacoustic and Ultrasonic Imaging
- Graphene and Nanomaterials Applications
Papers in
-
- Lung Cancer Treatments and Mutations 2
- Oncology 5
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Tai‐Tong Wong (2 shared papers)Feng‐Yi Yang (1 shared paper)Ru‐Shi Liu (1 shared paper)Hsiang‐Fa Liang (1 shared paper)Li Liu (2 shared papers)Chien Ho (2 shared papers)Feng Yang (1 shared paper)Ming-Cheng Wei (2 shared papers)
- Journals
- Scientific Reports (2 papers)Journal of Controlled Release (2 papers)Supportive Care in Cancer (2 papers)Acta Biomaterialia (1 paper)Cancer Biology & Therapy (1 paper)
- Partner nations
- United StatesTaiwanVietnam
In The Last Decade
Maggie Lu
15 papers receiving 438 citations
Peers
Comparison fields: 5 of 89
- Biomaterials 180
- Biomedical Engineering 234
- Molecular Medicine 26
- Pharmaceutical Science 26
- Radiology, Nuclear Medicine and Imaging 72
Countries citing papers authored by Maggie Lu
This map shows the geographic impact of Maggie Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie Lu more than expected).
Fields of papers citing papers by Maggie Lu
This network shows the impact of papers produced by Maggie Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie Lu. The network helps show where Maggie Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Maggie Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 148 | |
| 2 | 2012 | 59 | |
| 3 | 2015 | 57 | |
| 4 | 2015 | 44 | |
| 5 | 2019 | 42 | |
| 6 | 2017 | 29 | |
| 7 | 2015 | 18 | |
| 8 | 2013 | 13 | |
| 9 | 2015 | 13 | |
| 10 | 2007 | 9 | |
| 11 | 2018 | 9 | |
| 12 | The Harvard Business School guide to careers in management consulting | 2001 | 5 |
| 13 | 2016 | 3 | |
| 14 | 2024 | 1 | |
| 15 | 2013 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2024 | 0 |
About Maggie Lu
Maggie Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biomaterials, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, having authored 17 papers that have together received 451 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Cancer Treatment and Pharmacology (2 papers), Ultrasound Imaging and Elastography (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Photoacoustic and Ultrasonic Imaging (2 papers), Lung Cancer Treatments and Mutations (2 papers), Ultrasound and Hyperthermia Applications (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Biomaterials (180 citations), Biomedical Engineering (234 citations), Molecular Medicine (26 citations), Pharmaceutical Science (26 citations) and Radiology, Nuclear Medicine and Imaging (72 citations). Maggie Lu has collaborated with scholars based in United States, Taiwan and Vietnam. Frequent co-authors include Tai‐Tong Wong, Feng‐Yi Yang, Ru‐Shi Liu, Hsiang‐Fa Liang, Li Liu, Chien Ho, Feng Yang, Ming-Cheng Wei, Yuan‐Hung Hsu and Qing Ye. Their work appears in journals such as Scientific Reports, Journal of Controlled Release, Supportive Care in Cancer, Acta Biomaterialia and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.